Antibiotics Drugs Market By Drug Class 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antibiotics Drugs Market
Antibiotics Drugs Market: By Drug Class (Phenicols, Quinolones, Macrolides, Sulfonamides, Aminoglycosides, Tetracyclines, Beta lactam, Penicillin and Others) and By Geography (Europe, APAC, North America and ROW) – With Forecast (2016-2021)
Report Code : HCR 0151
Updated Date: 27 January, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Antibiotics Drugs – Market Overview
2. Executive Summary
3. Antibiotics Drugs Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Antibiotics Drugs – Market Forces
   4.1. Drivers
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Antibiotics Drugs Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Antibiotics Drugs Market, By Drug Class
   6.1. Phenicols
   6.2. Quinolones
   6.3. Macrolides
   6.4. Sulfonamides
   6.5. Aminoglycosides
   6.6. Tetracyclines
   6.7. Beta lactam
   6.8. Penicillin
   6.9. Others
7. Antibiotics Drugs Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Antibiotics Drugs – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. GLAXO SMITHKLINE PLC
      9.1.1.  Introduction
      9.1.2. Financials
      9.1.3. Key Insights
      9.1.4. Key Strategy
      9.1.5. Product Portfolio
      9.1.6. SWOT Analysis
   9.2. JOHNSON & JOHNSON
      9.2.1. Introduction
      9.2.2. Financials
      9.2.3. Key Insights
      9.2.4. Key Strategy
      9.2.5. Product Portfolio
      9.2.6. SWOT Analysis
   9.3. SANOFI-AVENTIS     
      9.3.1. Introduction
      9.3.2. Financials
      9.3.3. Key Insights
      9.3.4. Key Strategy
      9.3.5. Product Portfolio
      9.3.6. SWOT Analysis
   9.4. ENANTA PHARMACEUTICALS     
      9.4.1. Introduction
      9.4.2. Financials
      9.4.3. Key Insights
      9.4.4. Key Strategy
      9.4.5. Product Portfolio
      9.4.6. SWOT Analysis
   9.5. BAYER SCHERING PLOUGH AG  
      9.5.1. Introduction
      9.5.2. Financials
      9.5.3. Key Insights
      9.5.4. Key Strategy
      9.5.5. Product Portfolio
      9.5.6. SWOT Analysis
   9.6. MERCK & CO. INC.    
      9.6.1. Introduction
      9.6.2. Financials
      9.6.3. Key Insights
      9.6.4. Key Strategy
      9.6.5. Product Portfolio
      9.6.6. SWOT Analysis
   9.7. PFIZER, INC. 
      9.7.1. Introduction
      9.7.2. Financials
      9.7.3. Key Insights
      9.7.4. Key Strategy
      9.7.5. Product Portfolio
      9.7.6. SWOT Analysis
   9.8. WYETH PHARMACEUTICALS  
      9.8.1. Introduction
      9.8.2. Financials
      9.8.3. Key Insights
      9.8.4. Key Strategy
      9.8.5. Product Portfolio
      9.8.6. SWOT Analysis
   9.9. NOVARTIS INTERNATIONAL AG
      9.9.1. Introduction
      9.9.2. Financials
      9.9.3. Key Insights
      9.9.4. Key Strategy
      9.9.5. Product Portfolio
      9.9.6. SWOT Analysis
   9.10. LG LIFE SCIENCES LIMITED      
      9.10.1. Introduction
      9.10.2. Financials
      9.10.3. Key Insights
      9.10.4. Key Strategy
      9.10.5. Product Portfolio
      9.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Antibiotics are a group of medicines that are used to treat infections caused by germs (bacteria and certain parasites). A parasite is a type of germ that needs to live on or in another living being (host). This class of medicines are also sometimes called antibacterials or antimicrobials. Antibiotics are used for a range of other infections caused by bacteria, including urinary tract infections, skin infections and infected wounds. Antibiotics can be taken by mouth as liquids, tablets, or capsules, or they can be given by injection. Usually, people who need to have an antibiotic by injection are in hospital because they have a severe infection. This report is focused on identifying market size for anti-biotic drug. Increasing bacterial infection coupled with increasing investment and R&D activities in the field for antibiotics drugs are some of the major drivers for the growth of the anti-biotic drugs.

This report identifies the anti-biotic drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to anti-biotic drugs market.

Antibiotics Drugs Market

Globally North America is the largest market for antibiotic drugs in 2015 followed by Europe and Asia-Pacific as second and third largest regional markets respectively in 2015 for antibiotic drugs. However anti-biotic market in Asia-Pacific region is expected to grow fastest due to increasing demand of anti-biotic drugs in the region due to higher trends of self-medication practices amongst the people for normal health related issues.
  • On the basis of anti-biotic drug class this report is classified as follows covering all major types of drugs classes available in the market: Phenicols, Quinolones, Macrolides, Sulfonamides, Aminoglycosides, Tetracyclines, Beta lactam, Penicillin and Others
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for anti-biotic drugs in each of the region.

This report identifies all the major companies operating in the global anti-biotic drugs market. Some of the major companies’ profiles in detail are as follows:
  • Glaxo Smithkline Plc
  • Johnson & Johnson
  • Sanofi-Aventis     
  • Enanta Pharmaceuticals     
  • Bayer Schering Plough Ag  
  • Merck & Co. Inc.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll